Yiru Wang

1.5k total citations
48 papers, 969 citations indexed

About

Yiru Wang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Yiru Wang has authored 48 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 16 papers in Cancer Research and 12 papers in Immunology. Recurrent topics in Yiru Wang's work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (4 papers). Yiru Wang is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (4 papers). Yiru Wang collaborates with scholars based in China, United States and Macao. Yiru Wang's co-authors include Lian Li, Genlin Wang, John C. Bischof, Zhenpeng Qin, Kanav Khosla, Mary Hagedorn, Zhenzhen Zhan, Bo Wang, Xingguang Liu and Chengmin Li and has published in prestigious journals such as Nature Communications, ACS Nano and Cell Death and Differentiation.

In The Last Decade

Yiru Wang

44 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiru Wang China 17 579 273 108 89 86 48 969
Bei Zhen China 17 645 1.1× 123 0.5× 86 0.8× 108 1.2× 72 0.8× 21 1.2k
Janina M. Tomm Germany 14 622 1.1× 305 1.1× 122 1.1× 92 1.0× 31 0.4× 28 995
Yuko Ogawa Japan 19 815 1.4× 413 1.5× 144 1.3× 76 0.9× 72 0.8× 52 1.4k
Enrico Bracco Italy 23 622 1.1× 137 0.5× 114 1.1× 94 1.1× 45 0.5× 73 1.4k
Jing Guo China 20 715 1.2× 97 0.4× 83 0.8× 72 0.8× 82 1.0× 76 1.1k
Qingyang Zhang China 14 664 1.1× 300 1.1× 115 1.1× 41 0.5× 45 0.5× 55 1.1k
Lei Tang China 20 503 0.9× 173 0.6× 83 0.8× 83 0.9× 63 0.7× 64 979
Yoshio Kodera Japan 21 824 1.4× 160 0.6× 105 1.0× 120 1.3× 46 0.5× 73 1.4k
Jingzi Zhang China 17 848 1.5× 187 0.7× 167 1.5× 50 0.6× 184 2.1× 48 1.3k
Xiaohua Ni China 18 1.2k 2.0× 566 2.1× 97 0.9× 159 1.8× 102 1.2× 43 1.6k

Countries citing papers authored by Yiru Wang

Since Specialization
Citations

This map shows the geographic impact of Yiru Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiru Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiru Wang more than expected).

Fields of papers citing papers by Yiru Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiru Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiru Wang. The network helps show where Yiru Wang may publish in the future.

Co-authorship network of co-authors of Yiru Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yiru Wang. A scholar is included among the top collaborators of Yiru Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiru Wang. Yiru Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Tianjiao, Hong Lin, Feiye Zhou, et al.. (2025). Hepatic CBP/p300 Orchestrate Amino Acid‐Driven Gluconeogenesis through Histone Crotonylation. Advanced Science. 12(41). e07635–e07635. 1 indexed citations
2.
Chen, Yibo, Mengmeng Jiang, Ping Liao, et al.. (2025). miR-125b-5p sensitizes colorectal cancer to anti-PD-L1 therapy by decreasing TNFR2 expression on tumor cells. Journal of Leukocyte Biology. 117(6).
3.
Ma, Ying, et al.. (2024). miR-200a-3p promotes the malignancy of endometrial carcinoma through negative regulation of epithelial-mesenchymal transition. Discover Oncology. 15(1). 243–243. 1 indexed citations
4.
Zhao, Fangqi, et al.. (2023). Maternal derived-galectin-3 impacts on placental-fetal development leading to FGR. Journal of Reproductive Immunology. 159. 104062–104062.
5.
6.
Wang, Yiru, Can Wang, Xue Guan, et al.. (2023). PRMT3‐Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma. Advanced Science. 10(36). e2303812–e2303812. 43 indexed citations
7.
Song, Ziguang, Mengmeng Wang, Weitao Shen, et al.. (2023). CHDTEPDB: Transcriptome Expression Profile Database and Interactive Analysis Platform for Congenital Heart Disease. Congenital Heart Disease. 18(6). 693–701. 42 indexed citations
9.
Wang, Yiru, Feiye Zhou, Mingzhu Li, et al.. (2022). MiR-34a-5p promotes hepatic gluconeogenesis by suppressing SIRT1 expression. Experimental Cell Research. 420(1). 113336–113336. 8 indexed citations
10.
Wang, Yiru, Shijie Zhang, Yang Bai, et al.. (2022). Development and Validation of Ferroptosis-Related LncRNA Biomarker in Bladder Carcinoma. Frontiers in Cell and Developmental Biology. 10. 809747–809747. 15 indexed citations
11.
Wang, Yiru, et al.. (2022). Natural products against inflammation and atherosclerosis: Targeting on gut microbiota. Frontiers in Microbiology. 13. 997056–997056. 9 indexed citations
12.
Ma, Xiaoxue, Yiru Wang, Qi Liu, et al.. (2022). Vaspin alleviates the lncRNA LEF1-AS1-induced osteogenic differentiation of vascular smooth muscle cells via the Hippo/YAP signaling pathway. Experimental Cell Research. 421(2). 113407–113407. 7 indexed citations
13.
Ali, Ilyas, Min Yang, Yiru Wang, et al.. (2021). Sodium propionate protect the blood-milk barrier integrity, relieve lipopolysaccharide-induced inflammatory injury and cells apoptosis. Life Sciences. 270. 119138–119138. 20 indexed citations
14.
Wang, Yiru, Chengmin Li, Julang Li, Genlin Wang, & Lian Li. (2020). Non-esterified Fatty Acid-Induced Reactive Oxygen Species Mediated Granulosa Cells Apoptosis Is Regulated by Nrf2/p53 Signaling Pathway. Antioxidants. 9(6). 523–523. 19 indexed citations
15.
Xl, Wang, et al.. (2020). UFL1 Alleviates LPS-Induced Apoptosis by Regulating the NF-κB Signaling Pathway in Bovine Ovarian Granulosa Cells. Biomolecules. 10(2). 260–260. 31 indexed citations
16.
Wang, Yiru, Yunduo Liu, Yue Guan, et al.. (2020). Integrated analysis of immune-related genes in endometrial carcinoma. Cancer Cell International. 20(1). 477–477. 10 indexed citations
17.
Li, Chengmin, Lian Li, Kunlin Chen, et al.. (2019). UFL1 Alleviates Lipopolysaccharide-Induced Cell Damage and Inflammation via Regulation of the TLR4/NF-κB Pathway in Bovine Mammary Epithelial Cells. Oxidative Medicine and Cellular Longevity. 2019. 1–17. 27 indexed citations
18.
Li, Chengmin, Xinling Wang, Lian Li, et al.. (2019). UFL1 modulates NLRP3 inflammasome activation and protects against pyroptosis in LPS-stimulated bovine mammary epithelial cells. Molecular Immunology. 112. 1–9. 35 indexed citations
19.
Chen, Kunlin, et al.. (2017). Long noncoding RNA and mRNA profiling in MDA-MB-231 cells following RNAi-mediated knockdown of SIRT7. OncoTargets and Therapy. Volume 10. 5115–5128. 6 indexed citations
20.
Wu, Meng, Ying Wang, Yiru Wang, et al.. (2017). Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-<em>co</em>-glycolic acid) nanobubbles for ultrasound imaging and therapy of prostate cancer. International Journal of Nanomedicine. Volume 12. 5313–5330. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026